Europe HRM Analysis Market

Europe High-Resolution Melting Analysis Market Size (2024 to 2029)

The Europe High-Resolution Melting Analysis Market size is estimated to grow from USD 71.03 million in 2024 to USD 83.14 million by 2029, registering a CAGR of 3.2% between 2024 to 2029.

The growing prevalence of incidence of chronic diseases such as cancer and various other infectious diseases, increasing importunity for personalized medicine, and growing imbalance in the European population's lifestyles are expected to drive the demand for the European HRM analysis market. Huge investments made by the key market players for the R & D, developing healthcare infrastructure, a wide range of these applications in epigenetic and digitalization of modifications are some of the other significant factors propelling the market growth. FDA grants for many treatments intended to run across a particular genomic profile depending upon the patient's tumor. In Europe, educational establishments and research centers have contributed to significant growth in this region's HRM analysis market between 2024 and 2029.

The low costs of other genotyping technologies and obstacles pertaining to data storage are expected to hinder the growth of the high-resolution melting analysis market growth in Europe.

This research report on Europe High-Resolution Melting Analysis Market has been segmented and sub-segmented into the following categories.

By Product And Service: 

• Instruments
• Reagents and Consumables
• Software and Services

By Application: 

• Mutation Discovery
• SNP Genotyping
• Species Identification
• Pathogen Identification
• Epigenetics

By End User: 

• Pharmaceutical and Biotechnology Companies
• Research Laboratories and Academic Institutes
• Hospitals and Diagnostic Centers

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regional Analysis:

The European HRM analysis market was the second-largest market in the global market in 2019. Within Europe, the German market is expected to hold a significant share in the HRM analysis market of Europe and is forecasted to grow at a CAGR of 10.1% and is estimated to have 11.3% of GDP. Rising demand for advanced technologies among the research instruments, investments for research and development activities from public and private organizations may lead the market to the region's growth. Robust institutional framework, constitutional changes, and growing combativeness are adding fuel to the market growth. The UK is the second leading nation in the region due to unused markets and technology advancements, which bolstered the high-resolution melting analysis market growth in Europe throughout the period.

Notable companies in the European High-Resolution Melting Analysis market are Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands). Other players in the market include Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.